BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17598863)

  • 1. Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis.
    Bredberg A; Jonsson S; Lindblom A; Björk P
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):113-9. PubMed ID: 17598863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study on in vitro characterization of dendritic cells.
    Eichler H; Nguyen XD; Roelen D; Celluzzi CM; McKenna D; Pamphilon D; Blair A; Read EJ; Takahashi TA; Szczepiorkowski ZM;
    Cytotherapy; 2008; 10(1):21-9. PubMed ID: 18202971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC.
    Martinson J; Bae J; Klingemann HG; Tam Y
    Cytotherapy; 2004; 6(5):487-97. PubMed ID: 15512915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
    J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
    Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
    Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a technology platform for large-scale clinical grade production of DC.
    Adamson L; Palmborg A; Svensson A; Lundqvist A; Hansson M; Kiessling R; Masucci G; Mellstedt H; Pisa P
    Cytotherapy; 2004; 6(4):363-71. PubMed ID: 16146889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
    Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
    J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
    Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
    Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte-derived dendritic cells in bipolar disorder.
    Knijff EM; Ruwhof C; de Wit HJ; Kupka RW; Vonk R; Akkerhuis GW; Nolen WA; Drexhage HA
    Biol Psychiatry; 2006 Feb; 59(4):317-26. PubMed ID: 16165108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antigen-presenting cells in human apical periodontitis lesions by flow cytometry and immunocytochemistry.
    Lukić A; Vasilijić S; Majstorović I; Vucević D; Mojsilović S; Gazivoda D; Danilović V; Petrović R; Colić M
    Int Endod J; 2006 Aug; 39(8):626-36. PubMed ID: 16872457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML.
    Litzow MR; Dietz AB; Bulur PA; Butler GW; Gastineau DA; Hoering A; Fink SR; Letendre L; Padley DJ; Paternoster SF; Tefferi A; Vuk-Pavlović S
    Cytotherapy; 2006; 8(3):290-8. PubMed ID: 16793737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
    Atta M; Papanicolaou N; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
    Van Driessche A; Van de Velde AL; Nijs G; Braeckman T; Stein B; De Vries JM; Berneman ZN; Van Tendeloo VF
    Cytotherapy; 2009; 11(5):653-68. PubMed ID: 19530029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.
    Lundell AC; Andersson K; Josefsson E; Steinkasserer A; Rudin A
    Infect Immun; 2007 Aug; 75(8):4097-104. PubMed ID: 17526743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AML-loaded DC generate Th1-type cellular immune responses in vitro.
    Xing D; Decker WK; Li S; Robinson SN; Yang H; Segal H; O'Connor S; Yao X; Komanduri KV; McMannis JD; Jones RB; de Lima M; Champlin RE; Shpall EJ
    Cytotherapy; 2006; 8(2):95-104. PubMed ID: 16698683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte enrichment from leukapheresis products by using the Elutra cell separator.
    Kim S; Kim HO; Baek EJ; Choi Y; Kim HS; Lee MG
    Transfusion; 2007 Dec; 47(12):2290-6. PubMed ID: 17764512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy.
    Hayden H; Friedl J; Dettke M; Sachet M; Hassler M; Dubsky P; Bachleitner-Hofmann T; Gnant M; Stift A
    J Immunother; 2009; 32(6):638-54. PubMed ID: 19483645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes.
    Haenssle H; Buhl T; Knudsen S; Krueger U; Rosenberger A; Reich K; Neumann C
    Exp Dermatol; 2008 Mar; 17(3):177-87. PubMed ID: 18081852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary Sjögren syndrome.
    Wildenberg ME; Welzen-Coppens JM; van Helden-Meeuwsen CG; Bootsma H; Vissink A; van Rooijen N; van de Merwe JP; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2009 Mar; 68(3):420-6. PubMed ID: 18397959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
    Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.